HyperHep B (hepatitis b immunoglobulin (human))
/ Grifols
- LARVOL DELTA
Home
Next
Prev
1 to 2
Of
2
Go to page
1
June 01, 2021
Grifols introduces HyperHEP B (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B
(PRNewswire)
- "Grifols...began commercializing HyperHEP B, a new formulation of its hepatitis B immune globulin [human] for hepatitis B postexposure prophylaxis...HyperHEP B will now be available to U.S. healthcare providers and patients in three sizes (0.5 mL neonatal syringe, 1 mL vial, and 5 mL vial) through all major distributors."
Launch US • Hepatitis B • Infectious Disease
June 01, 2021
"$GRFS $GIKLY Grifols introduces HyperHEP B® (hepatitis B immune globulin [human]), a new formulation to treat patients exposed to hepatitis B https://t.co/iCxIbX3HPm"
(@stock_titan)
Clinical • Hepatitis B • Hepatology • Infectious Disease • Inflammation
1 to 2
Of
2
Go to page
1